Evaluation of the impact of the COVID-19 pandemic on gestational diabetes screening: DIABE-COVID Survey
Endocrinol Diabetes Nutr (Engl Ed)
.
2023 Jan;70(1):69-71.
doi: 10.1016/j.endien.2022.07.010.
Epub 2023 Jan 20.
Authors
María M Goya
1
,
Marta Miserachs
2
,
Mercè Codina
3
,
Irene Vinagre
4
;
GEDE
Affiliations
1
Servicio de Obstetricia y Ginecología, Fundación Althaia, Hospital de Manresa, Barcelona, Spain. Electronic address:
[email protected]
.
2
Servicio de Obstetricia y Ginecología, Hospital Vall d'Hebron, Barcelona, Spain.
3
Servicio de Endocrinología, Hospital Son Espasses, Palma de Mallorca, Spain.
4
Servicio de Endocrinología, Hospital Clínico y Provincial de Barcelona, Barcelona, Spain.
PMID:
36710168
PMCID:
PMC9852305
DOI:
10.1016/j.endien.2022.07.010
No abstract available
Publication types
Letter
MeSH terms
Blood Glucose
COVID-19*
Diabetes, Gestational* / diagnosis
Diabetes, Gestational* / epidemiology
Female
Humans
Pandemics
Pregnancy
SARS-CoV-2
Substances
Blood Glucose